Toll Like Receptor Adaptor Molecule 1 (TICAM1) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Toll Like Receptor Adaptor Molecule 1 (TICAM1) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityToll Like Receptor Adaptor Molecule 1 (TICAM1)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formataffinity purified
Size0.01 mg, 0.02 mg, 0.05 mg
Concentration200ug/ml
ApplicationsWestern Blot (WB), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Formalin/Paraffin, ELISA (EIA)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThe antibody is a rabbit polyclonal antibody raised against TICAM1. It has beenselected for its ability to recognize TICAM1 in immunohistochemical staining andwestern blotting.
ImmunogenImmunogen: Recombinant TICAM1 (Gln443~Gln685) expressed in E Coli. Conjugated Antibody: The APC conjugated antibody version of this item is also available as catalog #MBS2079107
Other Names[TIR domain-containing adapter molecule 1; TIR domain-containing adapter molecule 1; TIR domain-containing adapter molecule 1; toll like receptor adaptor molecule 1; Proline-rich, vinculin and TIR domain-containing protein B; Putative NF-kappa-B-activating protein 502H; Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta; MyD88-3; TIR domain-containing adapter protein inducing IFN-beta]
Gene, Accession #[TICAM1], Gene ID: 148022, NCBI: NP_891549.1, UniProt: Q8IUC6
Catalog #MBS2027773
Price$110, $130, $175
Order / More InfoToll Like Receptor Adaptor Molecule 1 (TICAM1) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.